In vivo studies showed that when a single dose of the particles was injected directly in the tumor (but not intravenously) of the melanoma‐bearing animals, a 4.6‐fold decrease in the tumor volume was observed in the group receiving the PD1‐decorated particles. The gene discussed is PDCD1; the disease is melanoma.